Kura Oncology (KURA) EBIT (2010 - 2026)
Kura Oncology (KURA) reported EBIT of -$78.8 million for Q1 2026, down 21.82% year-over-year from -$100.8 million in Q1 2025, and down 139.85% quarter-over-quarter from $197.8 million in Q4 2025.
Kura Oncology (KURA) EBIT (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has 8 years of EBIT data on file, last reported at -$78.8 million in Q1 2026.
- EBIT for Q1 2026 came in at -$78.8 million, down 21.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$20.5 million (up 88.98% YoY), and the FY2025 annual result was -$303.6 million, down 57.16% from the prior year.
- EBIT slipped to -$78.8 million in Q1 2026 per KURA's latest filing, from $197.8 million in the prior quarter.
- Over five years, EBIT peaked at $197.8 million in Q4 2025 and troughed at -$78.8 million in Q1 2026.
- A 3-year average of -$28.4 million and a median of -$54.0 million in 2024 frame the typical range for EBIT.
- On a YoY basis, EBIT climbed as much as 1277.58% in 2025 and fell as far as 36.54% in 2025.
- A 3-year view of EBIT shows it stood at -$16.8 million in 2024, then jumped by 1277.58% to $197.8 million in 2025, then tumbled by 139.85% to -$78.8 million in 2026.
- Business Quant data shows KURA's EBIT at -$78.8 million in Q1 2026, $197.8 million in Q4 2025, and -$73.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn | -78.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.82 Mn |
| Dec 31, 2025 | 197.79 Mn |
| Sep 30, 2025 | -73.72 Mn |
| Jun 30, 2025 | -65.73 Mn |
| Mar 31, 2025 | -64.70 Mn |
| Dec 31, 2024 | -16.80 Mn |
| Sep 30, 2024 | -53.99 Mn |
| Jun 30, 2024 | -50.43 Mn |
| Mar 31, 2024 | -49.13 Mn |
| Dec 31, 2014 | -9,762.00 |
| Sep 30, 2014 | -4,764.00 |
| Jun 30, 2014 | -5,242.00 |
| Mar 31, 2014 | -4,138.00 |
| Dec 31, 2013 | -8,087.00 |
| Sep 30, 2013 | -4,475.00 |
| Jun 30, 2013 | -5,456.00 |
| Mar 31, 2013 | -4,716.00 |
| Dec 31, 2012 | -8,376.00 |
| Sep 30, 2012 | -4,728.00 |
| Jun 30, 2012 | -4,996.00 |